|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Accounts receivable, net | ||
| Accounts receivable – related parties | ||
| Contract assets, net | ||
| Loan receivable, net | ||
| Marketable equity securities | ||
| Amount due from a related party, net | ||
| Prepayments and other current assets, net | ||
| Total current assets | ||
| Non-current assets | ||
| Property, plant and equipment, net | ||
| Right-of-use assets | ||
| Total non-current assets | ||
| TOTAL ASSETS | ||
| Current liabilities | ||
| Accounts payable | ||
| Accounts payable – related parties | ||
| Contract liabilities | ||
| Other payables and accrued liabilities | ||
| Provisions for compensation and penalty | ||
| Tax payables | ||
| Lease liabilities – current | ||
| Borrowings | ||
| Amounts due to related parties | ||
| Warrant liabilities | ||
| Dividend payables | ||
| Total current liabilities | ||
| Non-current liability | ||
| Lease liabilities – non-current | ||
| Total non-current liability | ||
| TOTAL LIABILITIES | ||
| EQUITY (DEFICIT) | ||
| Ordinary shares, par value $0.0008 per share, 62,500,000 shares authorized including 50,000,000 Ordinary Shares and 12,500,000 Undesignated Shares; 3,247,117 and 8,623,102 issued and outstanding as of December 31, 2024 and 2025, respectively* | ||
| Additional paid-in capital | ||
| Retained earnings (Accumulated deficit) | ||
| Accumulated other comprehensive loss | ||
| Total shareholders’ equity (deficit) | ||
| Non-controlling interest | ||
| TOTAL EQUITY (DEFICIT) | ||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
Loading...
